StartUPDATES: New developments from healthcare startups
Check out new developments from Healthmine, Light Solutions Company, Zephyr AI, and more.
Precision oncology startup AnHeart Therapeutics co-founder shares cancer drug strategy
AnHeart Therapeutics is developing a pipeline of precision oncology therapeutics. Chief Business Officer and Co-founder Lihua Zheng provided an overview of company's strategy in response to emailed questions.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Precision medicine: A new dimension to improve care outcomes
All the hype around precision medicine can make it seem intimidating and foreign. The good news is that it does not represent a departure from current clinical practice, and it can significantly improve patient care.
Sema4 secures a deal to acquire GeneDx, capturing $200M in private investment
The transaction also brought a $200 million investment for Sema4 from life science investors including Pfizer, which can help the combined company's goal of translating insights from genomics data and analytics into making precision medicine a standard of care.
In an age of precision medicine, decentralized clinical trials are a valuable tool
ntegrated software, accessible genetic data, and advances in precision medicine can transform the lives of millions of patients–if the clinical trial and larger medical industry embrace these trends.
Accelerating the adoption of precision medicine through collaborative efforts across the healthcare industry
While much progress has been made, many patients have molecular drivers of disease that are not detected, interpreted and acted upon with precision therapies, leaving potential life-changing treatments on the table.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Patient equations will help us work out of the current pandemic and address the next
Neutralizing the next threat to public health requires a new mindset, a new development path that uses computers and algorithms working in concert with patients, physicians, and scientists.
Sema4 goes public via SPAC merger
With a goal of making precision medicine the standard of care at health systems, Sema4 struck a nearly $800 million deal with CM Life Sciences to go public. The company, which offers tools that combine genomic and clinical data to glean patient care insights, will get $500 million in cash proceeds to grow its business.
Hospital precision dosing is ramping up
Artificial intelligence and predictive models are making it increasingly easier for physicians and pharmacists to select the right treatment for the right patient at the right time.
INVEST Precision Medicine Pitch Perfect Health IT and Life Science tracks video highlights
Video from the Health IT and Life Science tracks of our Pitch Perfect contest at INVEST Precision Medicine is now available to view.
Maximize Revenue and Patient Care with Strategic Weight Loss Management
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Check out video highlights of INVEST Precision Medicine conference from pediatrics to funding trends
The INVEST Precision Medicine conference cast a spotlight on the role of children's hospitals, biopharma companies, diagnostic companies and startups in biopharma innovation. The video recordings of the conference sessions are now available to view.
INVEST Precision Medicine Conference Video: The State of Precision Medicine
Experts in precision medicine provide a broad overview of where we are and where we need to go to make the promise and potential of this sector a reality.
INVEST Precision Medicine Conference Video: Biologics and the Supply Chain Ballet
This panel highlights how different organizations in the biopharma supply chain are addressing the inherent challenges of producing and delivering cell and gene therapies and biologics.
INVEST Precision Medicine Conference Video: Software Supporting Biopharma R&D
This panel explores some of the diverse approaches companies are taking to improve efficiency and avert pitfalls in therapeutic development.
INVEST Precision Medicine Conference Video: How Can We Improve Health Equity in Precision Medicine?
Targeted therapies for certain types of cancer and rare disease offer new hope for these patient populations. But how can we ensure that these treatments are also developed with minority communities in mind?